Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin Watts

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Open Forum Infectious Diseases|September 30, 2020
Discordance Between Radiologic Findings and Molecular Testing in Patients With Underlying Hematologic Malignancy and Coronavirus Disease 2019Mohammed Raja, Yoichiro Natori, Aditya Chandorkar, et al.
Journal of Translational Medicine|September 6, 2019
Correction to: Pre-clinical evaluation of Minnelide as a therapy for acute myeloid leukemiaBhuwan Giri, Vineet K Gupta, Brianna Yaffe, et al.
Journal of Translational Medicine|May 22, 2019
Pre-clinical evaluation of Minnelide as a therapy for acute myeloid leukemiaBhuwan Giri, Vineet K Gupta, Brianna Yaffe, et al.
American Journal of Hematology|December 15, 2015
Routine interim disease assessment in patients undergoing induction chemotherapy for acute myeloid leukemia: Can we do better?Germán Campuzano-Zuluaga, Yehuda Deutsch, Matthew Salzberg, et al.
Therapeutic Advances in Hematology|September 18, 2024
Phase I/II study of the clinical activity and safety of GSK3326595 in patients with myeloid neoplasmsJustin Watts, Mark D Minden, Kimo Bachiashvili, et al.
NPJ Precision Oncology|July 2, 2025
Functional cure with single agent olutasidenib in relapsed IDH1/NPM1 co-mutated AMLJustin Watts, Tiffany Nong, Katarina Micin, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 25, 2021
Outcomes of Adult Acute Myeloid Leukemia Treated With Gemtuzumab-Ozogamicin: Cue To Optimized Chemotherapy BackboneAbhay Singh, Swapna Thota, Terrence Bradley, et al.
Journal of Hematology & Oncology|November 14, 2025
Olutasidenib for mutated IDH1 acute myeloid leukemia: final five-year results from the phase 2 pivotal cohortJorge Cortes, Antonio Curti, Pierre Fenaux, et al.
Leukemia|June 24, 2020
Bosutinib for pretreated patients with chronic phase chronic myeloid leukemia: primary results of the phase 4 BYOND studyAndreas Hochhaus, Carlo Gambacorti-Passerini, Camille Abboud, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2019
Development of 2 Bromodomain and Extraterminal Inhibitors With Distinct Pharmacokinetic and Pharmacodynamic Profiles for the Treatment of Advanced MalignanciesGerald Falchook, Seth Rosen, Patricia LoRusso, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Open Forum Infectious Diseases|September 30, 2020
Discordance Between Radiologic Findings and Molecular Testing in Patients With Underlying Hematologic Malignancy and Coronavirus Disease 2019Mohammed Raja, Yoichiro Natori, Aditya Chandorkar, et al.
Journal of Translational Medicine|September 6, 2019
Correction to: Pre-clinical evaluation of Minnelide as a therapy for acute myeloid leukemiaBhuwan Giri, Vineet K Gupta, Brianna Yaffe, et al.
Journal of Translational Medicine|May 22, 2019
Pre-clinical evaluation of Minnelide as a therapy for acute myeloid leukemiaBhuwan Giri, Vineet K Gupta, Brianna Yaffe, et al.
American Journal of Hematology|December 15, 2015
Routine interim disease assessment in patients undergoing induction chemotherapy for acute myeloid leukemia: Can we do better?Germán Campuzano-Zuluaga, Yehuda Deutsch, Matthew Salzberg, et al.
Therapeutic Advances in Hematology|September 18, 2024
Phase I/II study of the clinical activity and safety of GSK3326595 in patients with myeloid neoplasmsJustin Watts, Mark D Minden, Kimo Bachiashvili, et al.
NPJ Precision Oncology|July 2, 2025
Functional cure with single agent olutasidenib in relapsed IDH1/NPM1 co-mutated AMLJustin Watts, Tiffany Nong, Katarina Micin, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 25, 2021
Outcomes of Adult Acute Myeloid Leukemia Treated With Gemtuzumab-Ozogamicin: Cue To Optimized Chemotherapy BackboneAbhay Singh, Swapna Thota, Terrence Bradley, et al.
Journal of Hematology & Oncology|November 14, 2025
Olutasidenib for mutated IDH1 acute myeloid leukemia: final five-year results from the phase 2 pivotal cohortJorge Cortes, Antonio Curti, Pierre Fenaux, et al.
Leukemia|June 24, 2020
Bosutinib for pretreated patients with chronic phase chronic myeloid leukemia: primary results of the phase 4 BYOND studyAndreas Hochhaus, Carlo Gambacorti-Passerini, Camille Abboud, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2019
Development of 2 Bromodomain and Extraterminal Inhibitors With Distinct Pharmacokinetic and Pharmacodynamic Profiles for the Treatment of Advanced MalignanciesGerald Falchook, Seth Rosen, Patricia LoRusso, et al.
Pageof 4